Skip to main content

Quality of Life of Patients Over 80 Years Old with Implantable Cardioverter-Defibrillators

  • Chapter
  • First Online:
Psychological, Emotional, Social and Cognitive Aspects of Implantable Cardiac Devices

Abstract

Implantable cardioverter-defibrillators (ICD) are frequently used to prevent sudden cardiac death. ICDs are underutilized in the elderly population. Though randomized trials included few elderly patients over the age of 80, ICDs should not be withheld on the basis of age alone as the available evidence shows a mortality benefit in this population. Complication rates in the elderly are slightly higher in the early post-implantation period but late complications are significantly lower. Elderly patients more likely to have complications can be identified prior to implantation through use of a validated risk score. There is a paucity of evidence regarding quality of life after ICD implantation but current evidence suggests it is comparable to patients who did not receive a device. Younger patients were more likely to experience psychological distress though elderly patients who experienced complications also experienced distress. Psychological distress can be well managed with cognitive-behavioral therapy. There is no conclusive evidence to suggest worse psychological well-being after ICD shocks and further evidence is needed in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Cesario DA, Dec GW. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol. 2006;47(8):1507–17.

    Article  PubMed  Google Scholar 

  2. DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med. 2003;349(19):1836–47.

    Article  CAS  PubMed  Google Scholar 

  3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.

    Article  PubMed  Google Scholar 

  4. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014;64(11):1143–77.

    Article  PubMed  Google Scholar 

  5. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8.

    Article  CAS  PubMed  Google Scholar 

  6. Higgins SL, Daubert JL, Akhtar M. Who are the MADIT patients? Multicenter automatic defibrillator implantation trial. Am J Cardiol. 1997;80(5B):42F–6F.

    Article  CAS  PubMed  Google Scholar 

  7. Hess PL, Grau-Sepulveda MV, Hernandez AF, Peterson ED, Bhatt DL, Schwamm LH, et al. Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure. J Cardiovasc Electrophysiol. 2013;24(6):664–71.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Barra S, Providencia R, Paiva L, Heck P, Agarwal S. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace. 2015;17(2):174–86.

    Article  PubMed  Google Scholar 

  9. Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, et al. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes. 2015;8(2):179–86.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Pellegrini CN, Lee K, Olgin JE, Turakhia MP, Tseng ZH, Lee R, et al. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008;10(11):1296–301.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Duray G, Richter S, Manegold J, Israel CW, Gronefeld G, Hohnloser SH. Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication. J Interv Card Electrophysiol. 2005;14(3):169–73.

    Article  PubMed  Google Scholar 

  12. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2(1):16–24.

    Article  PubMed  Google Scholar 

  13. Earley A, Persson R, Garlitski AC, Balk EM, Uhlig K. Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups a systematic review. Ann Intern Med. 2014;160(2):111–21.

    Article  PubMed  Google Scholar 

  14. Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED. Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis. Cardiol J. 2011;18(5):503–14.

    Article  PubMed  Google Scholar 

  15. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2007;28(14):1746–9.

    Article  PubMed  Google Scholar 

  16. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51(3):288–96.

    Article  PubMed  Google Scholar 

  17. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353(14):1471–80.

    Article  CAS  PubMed  Google Scholar 

  18. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest study Hamburg. Canadian Implantable Defibrillator study. Eur Heart J. 2000;21(24):2071–8.

    Article  CAS  PubMed  Google Scholar 

  19. Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA, et al. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(5):549–56.

    Article  PubMed  Google Scholar 

  20. Armaganijan LV, Toff WD, Nielsen JC, Andersen HR, Connolly SJ, Ellenbogen KA, et al. Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol. 2012;35(2):131–4.

    Article  PubMed  Google Scholar 

  21. Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, et al. Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation. 2013;127(24):2383–92.

    Article  PubMed  Google Scholar 

  22. Ozcan KS, Osmonov D, Altay S, Donmez C, Yildirim E, Turkkan C, et al. Pacemaker implantation complication rates in elderly and young patients. Clin Interv Aging. 2013;8:1051–4.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Haines DE, Wang Y, Curtis J. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation. 2011;123(19):2069–76.

    Article  PubMed  Google Scholar 

  24. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20(9):1016–24.

    Article  CAS  PubMed  Google Scholar 

  25. Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, et al. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007;45(5):377–85.

    Article  PubMed  Google Scholar 

  26. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;87(5):488–93.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Tomzik J, Koltermann KC, Zabel M, Willich SN, Reinhold T. Quality of life in patients with an implantable cardioverter defibrillator: a systematic review. Front Cardiovasc Med. 2015;2:34.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Barros RT, Carvalho SM, Silva MA, Borges JB. Evaluation of patients’ quality of life aspects after cardiac pacemaker implantation. Rev Bras Cir Cardiovasc. 2014;29(1):37–44.

    Article  PubMed  PubMed Central  Google Scholar 

  29. May CD, Smith PR, Murdock CJ, Davis MJ. The impact of the implantable cardioverter defibrillator on quality-of-life. Pacing Clin Electrophysiol. 1995;18(7):1411–8.

    Article  CAS  PubMed  Google Scholar 

  30. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22(9):1305–13.

    Article  CAS  PubMed  Google Scholar 

  31. Herbst JH, Goodman M, Feldstein S, Reilly JM. Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol. 1999;22(6 Pt 1):915–26.

    Article  CAS  PubMed  Google Scholar 

  32. Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, et al. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol. 2015;31(3):270–7.

    Article  PubMed  Google Scholar 

  33. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol. 1998;32(7):1909–15.

    Article  CAS  PubMed  Google Scholar 

  34. Pauli P, Wiedemann G, Dengler W, Blaumann-Benninghoff G, Kuhlkamp V. Anxiety in patients with an automatic implantable cardioverter defibrillator: what differentiates them from panic patients? Psychosom Med. 1999;61(1):69–76.

    Article  CAS  PubMed  Google Scholar 

  35. Manzoni GM, Castelnuovo G, Compare A, Pagnini F, Essebag V, Proietti R. Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods. Front Psychol. 2015;6:39.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Goonewardene M, Barra S, Heck P, Begley D, Fynn S, Virdee M, et al. Cardioverter-defibrillator implantation and generator replacement in the octogenarian. Europace. 2015;17(3):409–16.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed AlTurki M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

AlTurki, A., Proietti, R., Borgia, F. (2017). Quality of Life of Patients Over 80 Years Old with Implantable Cardioverter-Defibrillators. In: Proietti, R., Manzoni, G., Pietrabissa, G., Castelnuovo, G. (eds) Psychological, Emotional, Social and Cognitive Aspects of Implantable Cardiac Devices. Springer, Cham. https://doi.org/10.1007/978-3-319-55721-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55721-2_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55719-9

  • Online ISBN: 978-3-319-55721-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics